Agarwal, Sri M. ; Rao, Naren P. ; Jhamnani, Kapil ; Venkatasubramanian, Ganesan ; Behere, Rishikesh V. ; Varambally, Shivarama ; Gangadhar, Bangalore N. (2011) Prolactin—A Biomarker for Antipsychotic Treatment Response? The Primary Care Companion For CNS Disorders, 13 (4). ISSN 2155-7780
Full text not available from this repository.
Official URL: http://doi.org/10.4088/PCC.11l01155
Related URL: http://dx.doi.org/10.4088/PCC.11l01155
Abstract
To the Editor: Antipsychotic-induced hyperprolactinemia, due to blockade of D2 receptors in the tubulo-infundibular dopaminergic pathway,1 has been examined predominantly from the perspectives of adverse effects.2 Interestingly, the “neuroleptic threshold” construct conceptualizes the D2/3 occupancy to underlie the clinical efficacy of antipsychotics.3 Antipsychotic-induced hyperprolactinemia, being a proxy indicator of D2 receptor occupancy of antipsychotics, is reported to be associated with clinical improvement in a short-term study.4 Intriguingly, prolactin has even been hypothesized to mediate the adaptive effects of antipsychotics.5 In this report, we describe association between hyperprolactinemia and clinical improvement during a 5-month treatment period.
| Item Type: | Article |
|---|---|
| Source: | Copyright of this article belongs to PUBLONS. |
| ID Code: | 118827 |
| Deposited On: | 30 May 2021 06:02 |
| Last Modified: | 30 May 2021 06:02 |
Repository Staff Only: item control page
